toxicities

Pharmacist and nurse-led melanoma immunotherapy clinic 1:39
Pharmacist and nurse-led melanoma immunotherapy clinic
Dharmisha Chauhan • 10 Oct 2019
Exploring the link between chemotherapy-induced toxicities 1:20
Exploring the link between chemotherapy-induced toxicities
Rachel Gibson • 23 Jun 2016
Overview of symposium focused on chemotherapy and irritable bowel syndrome 4:36
Overview of symposium focused on chemotherapy and irritable bowel syndrome
Jervoise Andreyev • 23 Jun 2016
Late psychological and physical burdens in adults diagnosed in childhood 1:50
Late psychological and physical burdens in adults diagnosed in childhood
Martin Schrappe • 27 Jan 2017
Bone-migrated prostate cancer and Radium-223 therapy 3:47
Bone-migrated prostate cancer and Radium-223 therapy
Neal Shore • 7 Oct 2016
The crossroads of targeted therapy and immunotherapy in lung cancer 1:20
The crossroads of targeted therapy and immunotherapy in lung cancer
Roy Herbst • 7 Oct 2016
Results of trial of ribociclib with everolimus and exemestane in breast cancer 1:11
Results of trial of ribociclib with everolimus and exemestane in breast cancer
Mafalda Olivera • 8 Sep 2016
Two trials, SOFT and TEXT, investigating combination treatments for patients with breast cancer 2:12
Two trials, SOFT and TEXT, investigating combination treatments for patients with breast cancer
Antonio Llombart • 8 Sep 2016
Key messages from the SCLC session at NCRI 2016 1:28
Key messages from the SCLC session at NCRI 2016
Corinne Faivre-Finn • 6 Nov 2016
Perspective on immune modulation to fight cancer 2:56
Perspective on immune modulation to fight cancer
Lieping Chen • 6 Nov 2016
Overview of the CONVERT trial in LS-SCLC 1:49
Overview of the CONVERT trial in LS-SCLC
Corinne Faivre-Finn • 6 Nov 2016
How to monitor and manage immunotherapy related events in lung cancer 2:28
How to monitor and manage immunotherapy related events in lung cancer
Alex Spira • 4 Dec 2016
The toxicities associated with immunotherapy in lung cancer patients 4:15
The toxicities associated with immunotherapy in lung cancer patients
Beth Eaby-Sandy • 4 Dec 2016
Results of ASCEND-4 trial of ceritinib versus chemotherapy in ALK+ NSCLC patients 5:15
Results of ASCEND-4 trial of ceritinib versus chemotherapy in ALK+ NSCLC patients
Gilberto De Castro Jr • 4 Dec 2016
Referring cancer patients to exercise professionals 0:38
Referring cancer patients to exercise professionals
Karen Mustian • 23 Jun 2016
Symptom clusters and oral oncology perspectives 1:56
Symptom clusters and oral oncology perspectives
Douglas Peterson • 23 Jun 2016
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals